• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STRYKER NEUROVASCULAR-UTAH-SALT LAKE CITY TREVO XP PROVUE RETRIEVER 4X20; CATHETER, THROMBUS RETRIEVER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STRYKER NEUROVASCULAR-UTAH-SALT LAKE CITY TREVO XP PROVUE RETRIEVER 4X20; CATHETER, THROMBUS RETRIEVER Back to Search Results
Catalog Number 90182
Device Problems Adverse Event Without Identified Device or Use Problem (2993); No Apparent Adverse Event (3189)
Patient Problems Embolus (1830); No Consequences Or Impact To Patient (2199)
Event Date 06/13/2019
Event Type  Injury  
Manufacturer Narrative
The subject device is unavailable to manufacturer.
 
Event Description
It was reported that embolization to new territory was observed during withdrawal the subject device.The affected territory clot was not retrieved but fragmented.The procedure was completed with a different device.No further information is available.
 
Manufacturer Narrative
Executive summary- update: the thrombectomy intervention was performed with other stent retriever in response to the embolization to new territory and patient¿s current condition is fine at home.The device history record (dhr) review confirmed that the device met all material, assembly and performance specifications.The subject device was not returned; therefore, physical as well as a functional evaluation could not be performed.Additional information provided by the customer indicated that embolization to new territory (m2 branch proximal to the primary occlusion) was observed during withdrawal of the subject device, thrombectomy intervention was performed with another stent retriever in response to the reported event, and the patient did not experience symptoms due to the embolization to new territory.The reported "patient embolus" is a known and anticipated complication to these types of procedures and patient condition and is listed as such in the device directions for use.Therefore, a probable cause of anticipated procedural complication was assigned to this reported event.
 
Event Description
It was reported that embolization to new territory was observed during withdrawal the subject device.The affected territory clot was not retrieved but fragmented.The procedure was completed with a different device.No further information is available.Update information: received additional information stated that the thrombectomy intervention was performed with other stent retriever in response to the embolization to new territory and patient¿s current condition is fine at home.
 
Manufacturer Narrative
B5: executive summary - updated - received update information on 12-sep-2019 stated that the embolization located at the middle cerebral artery (mca) m2 branch.
 
Event Description
It was reported that embolization to new territory was observed during withdrawal the subject device.The affected territory clot was not retrieved but fragmented.The procedure was completed with a different device.No further information is available.Update information: received additional information stated that the thrombectomy intervention was performed with other stent retriever in response to the embolization to new territory and patient¿s current condition is fine at home.Update information: received update information on 12-sep-2019 stated that the embolization located at the middle cerebral artery (mca) m2 branch.
 
Manufacturer Narrative
Section b1 : adverse event/product problem: corrected to no adverse event/product problem: section b2: outcomes attributed to ae: corrected to no other serious.Information received on 5-mar-2020 clarified that that there was no adverse event (embolization to new territory).Since there was no reported malfunction of the device that could have caused or contributed to the reported event, this event does not meet reporting criteria anymore and the reportability will be changed from reportable to non-reportable with the new awareness date of on 5-mar-2020.In addition, the device did not cause or contribute to any adverse event.Nor was it related to a malfunction or deterioration in the characteristics or performance of the device or labeling issues.The manufacturer has reviewed all information and determined this event no longer meets the requirement of the reportable event for the device in question.
 
Event Description
It was reported that embolization to new territory was observed during withdrawal the subject device.The affected territory clot was not retrieved but fragmented.The procedure was completed with a different device.No further information is available.Update information: received additional information stated that the thrombectomy intervention was performed with other stent retriever in response to the embolization to new territory and patient¿s current condition is fine at home.Update information: received update information on 12-sep-2019 stated that the embolization located at the middle cerebral artery (mca) m2 branch.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TREVO XP PROVUE RETRIEVER 4X20
Type of Device
CATHETER, THROMBUS RETRIEVER
Manufacturer (Section D)
STRYKER NEUROVASCULAR-UTAH-SALT LAKE CITY
4870 west 2100 south
salt lake city UT 84120
MDR Report Key8860101
MDR Text Key153243840
Report Number3012931345-2019-00067
Device Sequence Number1
Product Code NRY
Combination Product (y/n)N
PMA/PMN Number
K132641
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type study
Type of Report Initial,Followup,Followup,Followup
Report Date 03/16/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/26/2021
Device Catalogue Number90182
Device Lot Number0000021700
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 07/18/2019
Initial Date FDA Received08/05/2019
Supplement Dates Manufacturer Received08/28/2019
09/12/2019
03/05/2020
Supplement Dates FDA Received09/04/2019
09/18/2019
03/16/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age79 YR
-
-